Clinical Trial Update: PreDiction and Validation of Clinical CoursE of Coronary Artery DiSease With CT-Derived Non-Invasive HemodYnamic Phenotyping and Plaque Characterization (DESTINY Study)

View source ↗

Summary

The DESTINY study, sponsored by Samsung Medical Center, investigates CT-derived non-invasive hemodynamic phenotyping and plaque characterization to predict and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease

Snippet

Sponsor: Samsung Medical Center | Conditions: Acute Coronary Syndrome, Ischemic Heart Disease | Status: COMPLETED